These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9044335)

  • 1. Dialysis membranes in the year 2000: performance and biocompatibility.
    Akizawa T; Kinugasa E; Koiwa F; Kohjiro S; Ideura T
    Nephrol Dial Transplant; 1996; 11 Suppl 8():16-9. PubMed ID: 9044335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility in hemodialysis: clinical relevance in 1995.
    Shaldon S; Koch KM
    Artif Organs; 1995 May; 19(5):395-7. PubMed ID: 7625916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the biocompatibility of haemodialysis membranes.
    Schulman G; Hakim RM
    Nephrol Dial Transplant; 1991; 6 Suppl 2():10-3. PubMed ID: 1866056
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
    Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
    Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis membranes: A 2018 update.
    Olczyk P; Małyszczak A; Kusztal M
    Polim Med; 2018; 48(1):57-63. PubMed ID: 30740940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biocompatibility].
    Uematsu K; Akizawa T
    Nihon Rinsho; 2004 May; 62 Suppl 5():37-40. PubMed ID: 15197884
    [No Abstract]   [Full Text] [Related]  

  • 10. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 2-microglobulin removal by synthetic dialysis membranes. Mechanisms and kinetics of the molecule.
    Ronco C; Heifetz A; Fox K; Curtin C; Brendolan A; Gastaldon F; Crepaldi C; Fortunato A; Pietribasi G; Caberlotto A; Brunello A; Milan Manani S; Zanella M; La Greca G
    Int J Artif Organs; 1997 Mar; 20(3):136-43. PubMed ID: 9151148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biocompatibility and bioactivity of hemodialysis membranes: their impact in end-stage renal disease.
    Kohlová M; Amorim CG; Araújo A; Santos-Silva A; Solich P; Montenegro MCBSM
    J Artif Organs; 2019 Mar; 22(1):14-28. PubMed ID: 30006787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC; Ringoir SM
    Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

  • 15. High cut-off dialysis membranes: current uses and future potential.
    Gondouin B; Hutchison CA
    Adv Chronic Kidney Dis; 2011 May; 18(3):180-7. PubMed ID: 21531324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients.
    Pickett TM; Cruickshank A; Greenwood RN; Taube D; Davenport A; Farrington K
    Blood Purif; 2002; 20(2):161-6. PubMed ID: 11818679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis-related amyloidosis: importance of biocompatibility and age.
    Jadoul M
    Nephrol Dial Transplant; 1998; 13 Suppl 7():61-4. PubMed ID: 9870440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Biocompatibility of Dialysis Membranes.
    Kokubo K; Kurihara Y; Kobayashi K; Tsukao H; Kobayashi H
    Blood Purif; 2015; 40(4):293-7. PubMed ID: 26656534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
    Strokov AG; Baeva LB; Levitskiĭ ER
    Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialyzer performance: biological indices.
    Holmes CJ
    Artif Organs; 1995 Nov; 19(11):1126-35. PubMed ID: 8579525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.